Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure

T A Slotkin1, C A Tate, M M Cousins

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Box 3813 DUMC, Durham, NC 27710, USA. t.slotkin@duke.edu

Insights

Neonatal exposure to chlorpyrifos (CPF), a common pesticide, impairs brain catecholamine systems long-term. These neurodevelopmental effects persist into adulthood, impacting synaptic function and responsiveness.

Area of Science:

  • Neuroscience
  • Environmental Toxicology
  • Developmental Neurobiology

Background:

  • Chlorpyrifos (CPF) is a widely used pesticide with known neurobehavioral teratogenic effects in animals.
  • Neonatal exposure to CPF can impact developing nervous systems even at doses without overt toxicity.

Purpose of the Study:

  • To investigate the long-term effects of neonatal chlorpyrifos exposure on catecholaminergic systems in rats.
  • To assess the impact on neurotransmitter content, utilization rates, and responsiveness to cholinergic stimulation.

Main Methods:

  • Neonatal rats were administered chlorpyrifos (CPF) on specific postnatal days.
  • Catecholamine systems (norepinephrine and dopamine) were analyzed in adolescence and adulthood.
  • Basal neurotransmitter levels, turnover rates, and responses to nicotine challenge were measured.

Main Results:

  • CPF exposure significantly suppressed norepinephrine turnover, indicating reduced presynaptic activity.
  • Dopamine turnover showed variable effects, with both reductions and activations observed.
  • Neonatal CPF exposure led to lasting desensitization of the nicotine-induced catecholamine response, with some responses reversed.

Conclusions:

  • Neonatal chlorpyrifos exposure causes persistent, widespread deficiencies in catecholaminergic synaptic function.
  • These deficits are best detected by dynamic measures of synaptic activity and responsiveness, not just basal levels.
  • The observed synaptic dysfunction likely contributes to long-lasting behavioral alterations.

Related Concept Videos

Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.